Major earnings reports. Berkshire Hathaway, Procter & Gamble, Exxon Mobil, Abbvie , Chevron , Hermès , Linde, Schneider Electric, EssilorLuxottica ...
- Caterpillar on Friday reported an increase in second-quarter adjusted profit, buoyed by demand for construction equipment amid a global economic recovery. The stock is down 2.2% in premarket trading, however, as the construction equipment maker said it expects moderate quarter-over-quarter margin growth.
- Chevron reported its highest quarterly profit in six quarters on Friday thanks to a rebound in oil prices and announced a $2 billion to $3 billion share buyback program. The stock gained 1.6% in premarket trading.
- Procter & Gamble on Friday reported better-than-expected sales for its fourth-quarter off-year period, but the company issued a cost warning due to raw material and transportation costs that will cut $1.9 billion from its earnings in fiscal 2021-2022. The stock is up 1.5% in pre-market trading.
- Exxon Mobil on Friday reported better-than-expected second-quarter earnings per share, excluding special items, thanks to a rebound in demand for oil, gas and chemicals. The stock was up just under 1% in premarket trading.
- AbbVie raised its full-year profit forecast on Friday, helped by a jump in demand for its anti-wrinkle product Botox. However, the stock is down 1.9% in pre-market trading.
- L'Oréal: first-half profit up 30%, boosted by sales of perfumes and make-up.
- Hermès: sales jump 77% year-on-year.
- Euronext: acquisition of Milan stock exchange weighs on earnings, up 5.4% on 2020.
- BNP Paribas: Q2 results up, optimistic for the rest of the year.
- EssilorLuxottica: raises annual guidance, revenue up 9.2% over 2019.
- Amazon increases profits by 48% to 7.8 billion in Q2.
- Unicredit in talks with Rome to buy Monte dei Paschi.
- Enel increases its investments in the first half of the year, which weighs on the profit.
- Robinhood gets off to a rocky start as it takes its first steps on the stock market.
- Bayer books an additional charge of 4.5 billion dollars on Roundup.
- Leonardo triples its first half profit.
- Colruytau increases its annual sales by 3.7%.
- Gilead Sciences sells $829 million of its anti-Covid drug.
- Uber imposes the vaccine on its US employees.
- Aperam announces a share buyback program.